Ardelyx, Inc. - Common Stock (ARDX)

Ardelyx Inc is a biopharmaceutical company focused on developing innovative therapies for patients with gastrointestinal and kidney-related diseases

The company is committed to creating targeted treatments that address significant unmet medical needs, leveraging its proprietary platform to discover and advance novel compounds. Ardelyx’s research and development efforts aim to improve the quality of life for patients suffering from conditions such as chronic kidney disease and irritable bowel syndrome, with a focus on delivering effective and safe therapeutic options.